DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axisXu Zhao, Yunfeng Zhang|Scientific Reports|2021Cited by 19
RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomasXu Zhao, Xiaozhi Zhang|Scientific Reports|2022Cited by 18